Successful use of thalidomide in treating metastatic Crohn’s disease
- 2 June 2026
- journal article
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 153 (3) , 103492
Abstract
No abstract availableFunding Information
- Assistance Publique - Hôpitaux de Paris
This publication has 7 references indexed in Scilit:
- Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn DiseaseJAMA Dermatology, 2025
- Management of Crohn DiseaseJAMA, 2021
- Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2016
- Long‐term outcomes of thalidomide in refractory Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2014
- Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn DiseaseJAMA, 2013
- Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapiesAlimentary Pharmacology & Therapeutics, 2007
- Thalidomide in Refractory Vulvar Ulcerations Associated with Crohn’s DiseaseDermatology, 2003